Charles Schwab Investment Management Inc. Increases Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Charles Schwab Investment Management Inc. increased its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 7.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 549,709 shares of the construction company’s stock after buying an additional 40,279 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Aspen Aerogels were worth $6,531,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in ASPN. Quest Partners LLC increased its stake in shares of Aspen Aerogels by 263.3% during the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after acquiring an additional 5,361 shares during the last quarter. Kovitz Investment Group Partners LLC purchased a new stake in Aspen Aerogels in the third quarter valued at approximately $263,000. Morse Asset Management Inc acquired a new position in Aspen Aerogels during the third quarter worth approximately $264,000. Maven Securities LTD purchased a new position in Aspen Aerogels during the third quarter worth approximately $415,000. Finally, Journey Strategic Wealth LLC acquired a new position in shares of Aspen Aerogels in the 4th quarter valued at $178,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Stock Up 0.9 %

NYSE ASPN opened at $7.10 on Tuesday. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels, Inc. has a fifty-two week low of $6.60 and a fifty-two week high of $33.15. The business has a 50 day moving average price of $9.50 and a two-hundred day moving average price of $15.11. The stock has a market cap of $583.11 million, a PE ratio of 44.39 and a beta of 2.28.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th. Roth Mkm dropped their price target on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Friday, February 14th. Seaport Res Ptn lowered Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. Canaccord Genuity Group decreased their target price on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. Finally, B. Riley reduced their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research report on Wednesday, February 19th. One analyst has rated the stock with a sell rating, one has given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $19.11.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.